Novo Nordisk Shares Post Worst Ever Week as Optimism Wanes | Company Business News
(Bloomberg) -- Just six weeks ago, things seemed to be getting better…
Who is Maziar Mike Doustdar? Novo Nordisk names new CEO to tackle ‘market challenges’ | Company Business News
Danish drug-making company Novo Nordisk has named Mazir Mike Doustdar as its…
Torrent aims to be among first cos to launch Wegovy, Ozempic generics in Brazil
Torrent Pharmaceuticals Ltd aims to be in the first wave of generic…
Cipla to enter into weight management segment in India, says MD Umang Vohra | Company Business News
Drugmaker Cipla’s MD and global CEO Umang Vohra has announced that the…
Obesity drug prices are dropping, but getting a steady supply remains a challenge | Company Business News
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but…
Novo Nordisk stirs up the weightloss drugs segment in India with Wegovy
Vikrant Shrotriya, Corporate Vice President and Managing Director, Novo Nordisk India Mumbai Danish healthcare company…
A ‘test case’ unfolds over Novo Nordisk’s weight loss and diabetes drug semaglutide
Semaglutide is the active ingredient in globally popular drug Ozempic/Wegovy | Photo…
Don’t expect immediate impact of US tariff threat, price cuts on business, says Cipla head | Company Business News
Cipla does not expect any immediate impact from potential tariffs imposed by…
Ozempic play: Mankind Pharma in the fray for weight-loss drugs
The pharma major is the latest among the country’s top generics drugmakers,…